Jun-Hyeog Jang

Prof. Jun-Hyeog Jang

Department of Biochemistry, Inha University, Incheon, Republic of Korea
orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2010 in Journal of Tissue Engineering
Verified
Journal Article
Open access
YYYe-Rang Yun
Ye-Rang Yun
JWJong Eun Won
Jong Eun Won
EJEunyi Jeon
Eunyi Jeon
SLSujin Lee
Sujin Lee
WKWonmo Kang
Wonmo Kang
Hae-Won KimHae-Won Kim
Hae-Won Kim
Fibroblast growth factors (FGFs) that signal through FGF receptors (FGFRs) regulate a broad spectrum of biological functions, including cellular proliferation, survival, migration, and differentiation. The FGF signal pathways are the RAS/MAP kinase pathway, PI3 kinase/AKT pathway, and PLCγ pathway, among which the RAS/MAP kinase pathway is known to be predominant. Several studies have recently implicated the in vitro biological functions of FGFs for tissue regeneration. However, to obtain optimal outcomes in vivo, it is important to enhance the half-life of FGFs and their biological stability. Future applications of FGFs are expected when the biological functions of FGFs are potentiated through the appropriate use of delivery systems and scaffolds. This review will introduce the biology and cellular functions of FGFs and deal with the biomaterials based delivery systems and their current applications for the regeneration of tissues, including skin, blood vessel, muscle, adipose, tendon/ligament, cartilage, bone, tooth, and nerve tissues.

Verified
Journal Article
Open access
PDF file
DLDong-Sung Lee
Dong-Sung Lee
KKKyoung-Su Kim
Kyoung-Su Kim
WKWonmin Ko
Wonmin Ko
BLBin Li
Bin Li
GJGil-Saeng Jeong
Gil-Saeng Jeong
YKYoun-Chul Kim
Youn-Chul Kim
Sulfuretin is one of the major flavonoid components in Rhus verniciflua Stokes (Anacardiaceae) isolates. In this study, we investigated the protective effects of sulfuretin against tert-butyl hydroperoxide (t-BHP)-induced oxidative injury. The results indicated that the addition of sulfuretin before t-BHP treatment significantly inhibited cytotoxicity and reactive oxygen species (ROS) production in human liver-derived HepG2 cells. Sulfuretin up-regulated the activity of the antioxidant enzyme heme oxygenase (HO)-1 via nuclear factor E2-related factor 2 (Nrf2) translocation into the nucleus and increased the promoter activity of the antioxidant response element (ARE). Moreover, sulfuretin exposure enhanced the phosphorylation of c-Jun N-terminal kinase (JNK) and extracellular signal-regulated kinase 1/2 (ERK1/2), which are members of the mitogen-activated protein kinase (MAPK) family. Furthermore, cell treatment with a JNK inhibitor (SP600125) and ERK inhibitor (PD98059) reduced sulfuretin-induced HO-1 expression and decreased its protective effects. Taken together, these results suggest that the protective effect of sulfuretin against t-BHP-induced oxidative damage in human liver-derived HepG2 cells is attributable to its ability to scavenge ROS and up-regulate the activity of HO-1 through the Nrf2/ARE and JNK/ERK signaling pathways. Therefore, sulfuretin could be advantageous as a bioactive source for the prevention of oxidative injury.

1 July 2021 in Biomaterials
Verified
Journal Article
Closed access
HKHan-Sem Kim
Han-Sem Kim
JLJung-Hwan Lee
Jung-Hwan Lee
NMNandin Mandakhbayar
Nandin Mandakhbayar
GJGuang-Zhen Jin
Guang-Zhen Jin
SKSung-Jin Kim
Sung-Jin Kim
Hae-Won KimHae-Won Kim
Hae-Won Kim

24 August 2012 in PLOS ONE
Verified
Journal Article
Open access
PDF file
EJEunyi Jeon
Eunyi Jeon
YYYe-Rang Yun
Ye-Rang Yun
WKWonmo Kang
Wonmo Kang
SLSujin Lee
Sujin Lee
YKYoung-Hyag Koh
Young-Hyag Koh
Jun-Hyeog JangJun-Hyeog Jang
Jun-Hyeog Jang
Fibroblast growth factor18 (FGF18) belongs to the FGF family and is a pleiotropic protein that stimulates proliferation in several tissues. Bone marrow mesenchymal stem cells (BMSCs) participate in the normal replacement of damaged cells and in disease healing processes within bone and the haematopoietic system. In this study, we constructed FGF18 and investigated its effects on rat BMSCs (rBMSCs). The proliferative effects of FGF18 on rBMSCs were examined using an MTS assay. To validate the osteogenic differentiation effects of FGF18, ALP and mineralization activity were examined as well as osteogenic differentiation-related gene levels. FGF18 significantly enhanced rBMSCs proliferation (p<0.001) and induced the osteogenic differentiation by elevating ALP and mineralization activity of rBMSCs (p<0.001). Furthermore, these osteogenic differentiation effects of FGF18 were confirmed via increasing the mRNA levels of collagen type I (Col I), bone morphogenetic protein 4 (BMP4), and Runt-related transcription factor 2 (Runx2) at 3 and 7 days. These results suggest that FGF18 could be used to improve bone repair and regeneration.


5 November 2004 in FEBS Letters
Verified
Journal Article
Closed access
Jun-Hyeog JangJun-Hyeog Jang
Jun-Hyeog Jang